Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 16/20 | 0.51 |
| ▸ | VIPR2 | P41587 | 4/20 | 0.49 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.49 |
| ▸ | SCTR | P47872 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31353031 | 0.91 | GLP1R (0.51) | GLP1RVIPR1SCTR | |
| SCHEMBL30168716 | 0.90 | GLP1R (0.60) | GLP1RVIPR2VIPR1SCTR | |
| SCHEMBL31548692 | 0.90 | GLP1R (0.48) | GLP1RVIPR2VIPR1 | |
| SCHEMBL30432968 | 0.90 | VIPR1 (0.59) | GLP1RVIPR2VIPR1 | |
| SCHEMBL31410848 | 0.90 | GLP1R (0.62) | GLP1RSCTR | |
| SCHEMBL30368368 | 0.90 | GLP1R (0.42) | GLP1RVIPR2VIPR1 | |
| SCHEMBL30262223 | 0.89 | PTH1R (0.53) | VIPR2VIPR1 | |
| SCHEMBL30369010 | 0.89 | GLP1R (0.45) | GLP1RVIPR2VIPR1 | |
| SCHEMBL30168698 | 0.89 | GLP1R (0.63) | GLP1RSCTR | |
| SCHEMBL29797106 | 0.89 | KEAP1 (0.54) | GLP1RVIPR2VIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431570-A | Light chain and heavy chain variable region of anti-mycoplasma pneumoniae monoclonal antibody and application thereof | 陕西省人民医院(陕西省临床医学研究院) | 2025-02-14 | — | — | CN | claimed |
| CN-119431570-A | Light chain and heavy chain variable region of anti-mycoplasma pneumoniae monoclonal antibody and application thereof | 陕西省人民医院(陕西省临床医学研究院) | 2025-02-14 | — | — | CN | disclosed |